These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31344599)

  • 21. [Accidental narcotic and buprenorphine poisoning in children notified at the Marseille Poison Center between 1993 and 1999].
    Spadari M; Arditti J; Affaton MF; David JM; Valli M
    Therapie; 2000; 55(6):705-8. PubMed ID: 11234466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends and characteristics of naloxone therapy reported to US poison centers.
    Rege SV; Ngo DA; Ait-Daoud N; Sharma S; Verplancken E; Holstege CP
    Addiction; 2018 Dec; 113(12):2309-2315. PubMed ID: 29989286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poisoning in older adults: a 5-year experience of US poison control centers.
    Crouch BI; Caravati EM; Mitchell A; Martin AC
    Ann Pharmacother; 2004 Dec; 38(12):2005-11. PubMed ID: 15522976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015.
    Heise CW; Brooks DE
    J Med Toxicol; 2017 Sep; 13(3):245-248. PubMed ID: 27896660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of abuse, suspected suicidal intent, and fatalities related to the 7-day buprenorphine transdermal patch versus other opioid analgesics in the National Poison Data System.
    Coplan PM; Sessler NE; Harikrishnan V; Singh R; Perkel C
    Postgrad Med; 2017 Jan; 129(1):55-61. PubMed ID: 27922764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Root causes, clinical effects, and outcomes of unintentional exposures to buprenorphine by young children.
    Lavonas EJ; Banner W; Bradt P; Bucher-Bartelson B; Brown KR; Rajan P; Murrelle L; Dart RC; Green JL
    J Pediatr; 2013 Nov; 163(5):1377-83.e1-3. PubMed ID: 23993129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2014 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 32nd Annual Report.
    Mowry JB; Spyker DA; Brooks DE; McMillan N; Schauben JL
    Clin Toxicol (Phila); 2015; 53(10):962-1147. PubMed ID: 26624241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding abuse of buprenorphine/naloxone film versus tablet products using data from ASI-MV® substance use disorder treatment centers and RADARS® System Poison Centers.
    Butler SF; Black RA; Severtson SG; Dart RC; Green JL
    J Subst Abuse Treat; 2018 Jan; 84():42-49. PubMed ID: 29195592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex- and Age-specific Increases in Suicide Attempts by Self-Poisoning in the United States among Youth and Young Adults from 2000 to 2018.
    Spiller HA; Ackerman JP; Spiller NE; Casavant MJ
    J Pediatr; 2019 Jul; 210():201-208. PubMed ID: 31054768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th Annual Report.
    Gummin DD; Mowry JB; Spyker DA; Brooks DE; Fraser MO; Banner W
    Clin Toxicol (Phila); 2017 Dec; 55(10):1072-1252. PubMed ID: 29185815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in Teenagers' Nonopiod Substance Exposures Reported to Poison Control Centers, 2010-2015.
    Wright B; Mestan S; Ahrens M; Bottei E
    J Pediatr; 2018 May; 196():258-263. PubMed ID: 29525071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abuse, misuse, and suicidal substance use by children on school property.
    Vakkalanka JP; King JD; Holstege CP
    Clin Toxicol (Phila); 2015 Nov; 53(9):901-7. PubMed ID: 26503790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of non-therapeutic atomoxetine exposures--a national poison data system study.
    Monte AA; Ceschi A; Bodmer M
    Hum Psychopharmacol; 2013 Sep; 28(5):471-6. PubMed ID: 23861380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in types of calls managed by U.S. poison centers 2000-2015.
    Anderson BD; Seung H; Klein-Schwartz W
    Clin Toxicol (Phila); 2018 Jul; 56(7):640-645. PubMed ID: 29205070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketamine exposure demographics and outcomes over 16 years as reported to US poison centers.
    Ni A; Lee Cantrell F; Clark RF
    Am J Emerg Med; 2018 Aug; 36(8):1459-1462. PubMed ID: 29754964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Accidental ingestion of methadone and buprenorphine by children. A case review of the Lille Poison Centre between 1995 and 2005].
    Nisse P; Cezard C; Peucelle D; Mathieu-Nolf M
    Acta Clin Belg; 2006; 61 Suppl 1():37-40. PubMed ID: 16700149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric ADHD Medication Exposures Reported to US Poison Control Centers.
    King SA; Casavant MJ; Spiller HA; Hodges NL; Chounthirath T; Smith GA
    Pediatrics; 2018 Jun; 141(6):. PubMed ID: 29784754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lacosamide: a Study of Exposures Reported to US Poison Centers over a 9-Year Period.
    Teijido J; Kempf D; Laubach E; Zosel A; Borys D
    J Med Toxicol; 2019 Oct; 15(4):271-275. PubMed ID: 31286429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indicators for serious kidney complications associated with toxic exposures: an analysis of the National Poison Data System.
    Vilay AM; Wong CS; Schrader RM; Mercier RC; Seifert SA
    Clin Toxicol (Phila); 2013 Feb; 51(2):96-105. PubMed ID: 23331216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poisoning in Israel: annual report of the Israel Poison Information Center, 2007.
    Bentur Y; Lurie Y; Cahana A; Lavon O; Bloom-Krasik A; Kovler N; Gurevych B; Raikhlin-Eisenkraft B
    Isr Med Assoc J; 2008 Nov; 10(11):749-56. PubMed ID: 19070280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.